Ownership history in Alphabet Inc. · 14 quarters on record
This page tracks every 13F SEC filing in which Alphabet Inc. reported a position in Monte Rosa Therapeutics Inc. (GLUE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 744,948 | -719,067 | -49.1% | 0.45% | $11.7M | $15.68 |
| 2025 Q3 | UNCHANGED | 1,464,015 | — | 0% | 0.45% | $10.8M | $7.41 |
| 2025 Q2 | UNCHANGED | 1,464,015 | — | 0% | 0.31% | $6.6M | $4.51 |
| 2025 Q1 | UNCHANGED | 1,464,015 | — | 0% | 0.43% | $6.8M | $4.64 |
As of 2025 Q4 — sorted by position size